RSV in transplant and immunocompromised patients.

Humans Immunocompromised Host Respiratory Syncytial Virus Infections / immunology Antiviral Agents / therapeutic use Child Adult Infant

Journal

Cleveland Clinic journal of medicine
ISSN: 1939-2869
Titre abrégé: Cleve Clin J Med
Pays: United States
ID NLM: 8703441

Informations de publication

Date de publication:
04 Sep 2024
Historique:
medline: 5 9 2024
pubmed: 5 9 2024
entrez: 4 9 2024
Statut: epublish

Résumé

Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory disease. In this review we address the impact of RSV in immunocompromised populations, and discuss the limited available treatments and the potential impact of newer RSV prevention strategies on immunocompromised adults and children.

Identifiants

DOI: 10.3949/ccjm.91.s1.06 PMID: 39231600
pubmed: 39231600
pii: 91/9_suppl_1/S34
doi: 10.3949/ccjm.91.s1.06
doi:

Substances chimiques

Antiviral Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S34-S41

Informations de copyright

Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.

Auteurs

Christine E Koval (CE)

Section Head, Transplant Infectious Diseases, Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH; Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.

Blanca E Gonzalez (BE)

Center for Pediatric Infectious Diseases, Cleveland Clinic Children's Hospital, Cleveland, OH; Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH gonzalb3@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › RSV in transplant and immunocompromised patients.
questionsmedicales.fr › Phénomènes du système immunitaire › Sujet immunodéprimé › RSV in transplant and immunocompromised patients.
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Mononegavirales › Infections à Paramyxoviridae › Infections à pneumovirus › Infections à virus respiratoire syncytial › RSV in transplant and immunocompromised patients.
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiviraux › RSV in transplant and immunocompromised patients.
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › RSV in transplant and immunocompromised patients.
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › RSV in transplant and immunocompromised patients.
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › RSV in transplant and immunocompromised patients.